Encantados de anunciar que Viromii está participando en el proyecto...
Read MoreInsights
Insights
Divulgation: a fundamental support for innovation
Innovation can be defined in many ways; it is a...
Read More
Activity update during the COVID19 lockdown
Finally, after more than 3 months working remotely, we are...
Read More
Theranostics – An innovative approach against cancer.
During the past months, at Viromii we have been working...
Read More
Glucose monitoring – A vibrant area with a promising future
Recently, at Viromii we have been working with a new...
Read More
Biohub VLC – a first step for consolidating Valencia as a Biotech Hub?
In one of the most privileged environments of the city...
Read More
The 4 steps of our market validation analysis
As all of you know, we develop services for supporting...
Read More
Phage therapy, the solution for multiresistant bacteria?
Recently, at Viromii, we have been working on a really interesting...
Read More
Innovative strategies for extending drugs’ market exclusivity.
In the previous post, we explored the different preventive strategies pharma...
Read More
SME Phase 1, one last call and a long-lasting impact in almost 4000 Start-ups.
For some time at Viromii we have been developing a...
Read More
Preventive strategies for extending drugs’ market exclusivity in US and EU.
In the previous post we could see the greatly negative impact that...
Read More
When pharma companies lose control and exclusivity over a blockbuster.
Lately, at Viromii, we have been working with some really...
Read More
Guidelines for creating a TTO, what do you have to bear in mind before taking the step?
In the previous post, we explained the impact of the...
Read More
Professor’s privilege, does it really impact technology transfer?
Universities are the cradle of knowledge, new technologies and innovation....
Read More
Which are the most important performance parameters in ventures and startups?
We, at Viromii. have asked this question to many actors...
Read More